Program 80

Clinical particulars Target species: Cats greater than or equal to 4 kg bodyweight. Indications for use, specifying the target species The product is intended for the 6-month long-term prevention and control of flea infestations and the treatment of FAD (flea allergic dermatitis) in cats. The product is effective against the pre-audit stages of the dominant flea species, Ctenocephalides felis and C. canis. It can be administered to all cats, including weaned kittens as well as pregnant and lactating queens. Contra-indications None known. Special warnings for each target species Not to be used in dogs. In the cat, to achieve a six month flea control, a small subcutaneous depot is required. Injection site reaction may occur in some cats, in particular a small painless swelling at the injection site which disappears, in general, after a few weeks Special precautions for use i.Special precautions for use in animals For subcutaneous administration only. The injection should be carried out under aseptic conditions. ii.Special precautions to be taken by the person administering the medicinal product to the animals Care should be taken to avoid accidental self injection. In the case of accidental self injection seek medical advice. Avoid contact with skin and eyes. In the event of accidental eye or skin contact, wash/irrigate the area with clean running water. Seek medical attention if irritation persists. Wash hands after use. Adverse reactions (frequency and seriousness) The product is well tolerated by all cats but may cause a transient mild and painless reaction at the injection site. In rare cases, lethargy may occur for a few hours after injection, however, it quickly disappears Use during pregnancy, lactation or lay No harmful effects are to be expected when this product is given during pregnancy and lactation. Interaction with other medicinal products and other forms of interaction No evidence of interactions with other medicaments has been observed